JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6251
First Community Corp
FCCO
$307M
| $1K | ﹤0.01% |
36
+25
| +227% | +$509 |
2020 Q2
11 quarters
|
|
6252
Inspire Fidelis Multi Factor ETF
FDLS
$251M
| $1K | ﹤0.01% |
+40
| New | +$1.03K |
2023 Q1
0 quarters
|
|
6253
Fennec Pharmaceuticals
FENC
$358M
| $1K | ﹤0.01% |
70
| – | – |
2021 Q4
5 quarters
|
|
|
FINS
6254
Angel Oak Financial Strategies Income Term Trust
FINS
$400M
| $1K | ﹤0.01% |
53
-113
| -68% | -$1.46K |
2022 Q4
1 quarter
|
|
6255
Fidelity US Multifactor ETF
FLRG
$292M
| $1K | ﹤0.01% |
+23
| New | +$560 |
2023 Q1
0 quarters
|
|
|
GNT
6256
GAMCO Natural Resources, Gold & Income Trust
GNT
$143M
| $1K | ﹤0.01% |
+146
| New | +$751 |
2023 Q1
0 quarters
|
|
6257
Global X Gold Explorers ETF NEW
GOEX
$120M
| $1K | ﹤0.01% |
29
| – | – |
2021 Q3
6 quarters
|
|
6258
IceCure Medical
ICCM
$7.28M
| $1K | ﹤0.01% |
15
-315
| -95% | -$11.7K |
2022 Q4
1 quarter
|
|
6259
Immunic
IMUX
$109M
| $1K | ﹤0.01% |
41
-2,449
| -98% | -$45.5K |
2020 Q2
11 quarters
|
|
6260
Jaguar Health
JAGX
$1.9M
| – | – |
0
| – | – |
2021 Q4
5 quarters
|
|
|
NXDR
6261
Nextdoor Holdings
NXDR
$944M
| $1K | ﹤0.01% |
495
| – | – |
2022 Q2
3 quarters
|
|
|
KRKR
6262
36Kr Holdings
KRKR
$5.92M
| $1K | ﹤0.01% |
+27
| New | +$617 |
2023 Q1
0 quarters
|
|
6263
Pasithea Therapeutics
KTTA
$15.9M
| $1K | ﹤0.01% |
150
| – | – |
2021 Q4
5 quarters
|
|
6264
LENSAR
LNSR
$82.9M
| $1K | ﹤0.01% |
234
| – | – |
2020 Q4
9 quarters
|
|
6265
PIMCO Senior Loan Active Exchange-Traded Fund
LONZ
$638M
| $1K | ﹤0.01% |
15
| – | – |
2022 Q4
1 quarter
|
|
6266
Lipocine
LPCN
$16.9M
| $1K | ﹤0.01% |
176
| – | – |
2019 Q1
16 quarters
|
|
|
CYPH
6267
Cypherpunk Technologies Inc
CYPH
$327M
| $1K | ﹤0.01% |
337
+109
| +48% | +$572 |
2021 Q4
5 quarters
|
|
6268
Mustang Bio
MBIO
$3.57M
| $1K | ﹤0.01% |
3
| – | – |
2018 Q2
19 quarters
|
|
|
MIO
6269
DELISTED
Pioneer Municipal High Income Opportunities Fund
MIO
| $1K | ﹤0.01% |
47
-4,809
| -99% | -$53.4K |
2022 Q4
1 quarter
|
|
|
MVF
6270
DELISTED
BlackRock MuniVest Fund
MVF
| $1K | ﹤0.01% |
155
-3,741
| -96% | -$26K |
2022 Q3
2 quarters
|
|
6271
National CineMedia
NCMI
$198M
| $1K | ﹤0.01% |
+806
| New | +$1.88K |
2023 Q1
0 quarters
|
|
|
AIIO
6272
Robo.ai Inc
AIIO
$142M
| $1K | ﹤0.01% |
+5
| New | +$1.09K |
2023 Q1
0 quarters
|
|
|
IMDX
6273
Insight Molecular Diagnostics
IMDX
$113M
| $1K | ﹤0.01% |
155
| – | – |
2017 Q4
21 quarters
|
|
6274
Innovator US Equity Power Buffer ETF May
PMAY
$816M
| $1K | ﹤0.01% |
22
| – | – |
2022 Q4
1 quarter
|
|
|
PNF
6275
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $1K | ﹤0.01% |
+102
| New | +$942 |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.